Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shulman

Showing results (341-350 of 535) with videos related to

Pageof 54
Sort By:
Journal of Parkinson'S Disease|August 9, 2021
Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease SeverityAllison Snyder, Ann L Gruber-Baldini, F Rainer von Coelln, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 6, 2004
Prevention of Fas-mediated hepatic failure by transferrinVladimir A Lesnikov, Marina P Lesnikova, Howard M Shulman, et al.
Journal of Geriatric Psychiatry and Neurology|May 25, 2017
Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson DiseaseChristian Lachner, Melissa J Armstrong, Ann L Gruber-Baldini, et al.
Hepatology (Baltimore, Md.)|November 28, 2000
Chronic graft-versus-host disease of the liver: presentation as an acute hepatitisS I Strasser, H M Shulman, M E Flowers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1989
Acute renal failure following bone marrow transplantation: a retrospective study of 272 patientsR A Zager, J O'Quigley, B K Zager, et al.
Journal of Biological Regulators and Homeostatic Agents|February 21, 2018
Rehabilitations with immediate loading of one-piece implants stabilized with intraoral weldingM E Pasqualini, D Lauritano, F Rossi, et al.
Journal of Pharmaceutical Sciences|April 1, 1995
Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantificationS M Ludeman, E M Shulman-Roskes, K K Wong, et al.
Neurology|April 12, 2006
Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyJ M Miyasaki, K Shannon, V Voon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2008
The evolution of disability in Parkinson diseaseLisa M Shulman, Ann L Gruber-Baldini, Karen E Anderson, et al.
Parkinsonism & Related Disorders|October 7, 2011
What determines resilience in patients with Parkinson's disease?B J Robottom, A L Gruber-Baldini, K E Anderson, et al.
Pageof 54

Showing results (341-350 of 535) with videos related to

Sort By:
Pageof 54
Journal of Parkinson'S Disease|August 9, 2021
Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease SeverityAllison Snyder, Ann L Gruber-Baldini, F Rainer von Coelln, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 6, 2004
Prevention of Fas-mediated hepatic failure by transferrinVladimir A Lesnikov, Marina P Lesnikova, Howard M Shulman, et al.
Journal of Geriatric Psychiatry and Neurology|May 25, 2017
Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson DiseaseChristian Lachner, Melissa J Armstrong, Ann L Gruber-Baldini, et al.
Hepatology (Baltimore, Md.)|November 28, 2000
Chronic graft-versus-host disease of the liver: presentation as an acute hepatitisS I Strasser, H M Shulman, M E Flowers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1989
Acute renal failure following bone marrow transplantation: a retrospective study of 272 patientsR A Zager, J O'Quigley, B K Zager, et al.
Journal of Biological Regulators and Homeostatic Agents|February 21, 2018
Rehabilitations with immediate loading of one-piece implants stabilized with intraoral weldingM E Pasqualini, D Lauritano, F Rossi, et al.
Journal of Pharmaceutical Sciences|April 1, 1995
Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantificationS M Ludeman, E M Shulman-Roskes, K K Wong, et al.
Neurology|April 12, 2006
Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyJ M Miyasaki, K Shannon, V Voon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2008
The evolution of disability in Parkinson diseaseLisa M Shulman, Ann L Gruber-Baldini, Karen E Anderson, et al.
Parkinsonism & Related Disorders|October 7, 2011
What determines resilience in patients with Parkinson's disease?B J Robottom, A L Gruber-Baldini, K E Anderson, et al.
Pageof 54